| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8234349 | International Journal of Radiation Oncology*Biology*Physics | 2009 | 4 Pages |
Abstract
To our knowledge, this is the longest survival of any patient in the literature whose initial diagnosis was GB. Triple-positive GBM patients (MGMT methylated, PTEN, and p53 positive) are uncommon but may be associated with a better prognosis. Further research is needed to confirm whether this molecular profile is prognostic of prolonged survival. Molecular genetics will determine future treatment and prognosis in GB.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Christina Maria Sperduto, Arnab M.D., Ken M.D., Peter M.D., Gail Bender M.D., Paul M.D.,